279 related articles for article (PubMed ID: 19031946)
1. The role of podoplanin in tumor progression and metastasis.
Raica M; Cimpean AM; Ribatti D
Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946
[TBL] [Abstract][Full Text] [Related]
2. Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma.
Mishima K; Kato Y; Kaneko MK; Nakazawa Y; Kunita A; Fujita N; Tsuruo T; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 Jun; 111(6):563-8. PubMed ID: 16718353
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
4. Podoplanin expression in advanced-stage gastric carcinoma and prognostic value of lymphatic microvessel density.
Raica M; Ribatti D; Mogoanta L; Cimpean AM; Ioanovici S
Neoplasma; 2008; 55(5):455-60. PubMed ID: 18665758
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics.
Ji RC
Cancer Metastasis Rev; 2006 Dec; 25(4):677-94. PubMed ID: 17160713
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome.
Yuan P; Temam S; El-Naggar A; Zhou X; Liu DD; Lee JJ; Mao L
Cancer; 2006 Aug; 107(3):563-9. PubMed ID: 16804930
[TBL] [Abstract][Full Text] [Related]
7. The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.
Fiedler U; Christian S; Koidl S; Kerjaschki D; Emmett MS; Bates DO; Christofori G; Augustin HG
Am J Pathol; 2006 Mar; 168(3):1045-53. PubMed ID: 16507917
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
9. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.
Clarijs R; Schalkwijk L; Hofmann UB; Ruiter DJ; de Waal RM
Cancer Res; 2002 Dec; 62(23):7059-65. PubMed ID: 12460927
[TBL] [Abstract][Full Text] [Related]
10. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
Ordóñez NG
Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
[TBL] [Abstract][Full Text] [Related]
11. Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced tumours.
Ji RC; Eshita Y; Kato S
Int J Exp Pathol; 2007 Aug; 88(4):257-70. PubMed ID: 17696907
[TBL] [Abstract][Full Text] [Related]
12. Lymphangiogenesis in tumors: what do we know?
Reis-Filho JS; Schmitt FC
Microsc Res Tech; 2003 Feb; 60(2):171-80. PubMed ID: 12539171
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin as a marker for mesothelioma.
Kimura N; Kimura I
Pathol Int; 2005 Feb; 55(2):83-6. PubMed ID: 15693854
[TBL] [Abstract][Full Text] [Related]
14. [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma].
Breiteneder-Geleff S; Soleiman A; Horvat R; Amann G; Kowalski H; Kerjaschki D
Verh Dtsch Ges Pathol; 1999; 83():270-5. PubMed ID: 10714221
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of the lymphatic marker podoplanin in diverse types of human cancer cells using a novel antibody.
Kono T; Shimoda M; Takahashi M; Matsumoto K; Yoshimoto T; Mizutani M; Tabata C; Okoshi K; Wada H; Kubo H
Int J Oncol; 2007 Sep; 31(3):501-8. PubMed ID: 17671675
[TBL] [Abstract][Full Text] [Related]
16. From tumor lymphangiogenesis to lymphvascular niche.
Hirakawa S
Cancer Sci; 2009 Jun; 100(6):983-9. PubMed ID: 19385973
[TBL] [Abstract][Full Text] [Related]
17. Correlation between lymphatic endothelial markers and lymph node status or N-staging of colorectal cancer.
Zhang XM; Han WX; Wang HY; He Q
World J Surg Oncol; 2017 Nov; 15(1):204. PubMed ID: 29162097
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
[TBL] [Abstract][Full Text] [Related]
19. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms.
Yu H; Pinkus GS; Hornick JL
Am J Clin Pathol; 2007 Nov; 128(5):767-75. PubMed ID: 17951198
[TBL] [Abstract][Full Text] [Related]
20. Dual role of podoplanin in oral cancer development.
Cîrligeriu L; Cimpean AM; Raica M; Doroş CI
In Vivo; 2014; 28(3):341-7. PubMed ID: 24815836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
